Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...
A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...
In addition to enabling the manufacture of platelets on demand, the finding could help doctors better treat both cancer and thrombocytopenia, a clotting disorder that often strikes newborns in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results